Complete patient data for every therapeutic area
Thank you for your interest!
All data for your entire portfolio in one place
Truveta brings together complete patient journeys, including longitudinal clinical data, such as notes, images, and claims so teams can support one study or an entire portfolio across therapeutic areas, rare diseases, and complex populations.
Featured therapeutic areas
Cardiology
Research cardiovascular disease with unmatched depth
Metabolic diseases and endocrinology
Study metabolic disease with comprehensive clinical context
Neurology
Discover more from multimodal, longitudinal neurologic data
Oncology
Study all common and rare cancers with unparalleled breadth and depth
All therapeutic areas
Turn hidden clinical detail into new intelligence and evidence
The most nuanced signals are rarely contained in structured data alone. Truveta brings that context into view, giving teams a more complete understanding of patients and disease.
Truveta helps teams see patients with greater precision and imagine broader applications across AI training, clinical trials, safety, outcomes research, and therapy adoption.
Bring disease into focus with images
With imaging linked to the full patient journey, Truveta connects imaging studies and metadata with the patient context researchers need to enrich real-world evidence and train multimodal AI.
Truveta provides pixel data and imaging metadata including MRI, CT, X-ray, ultrasound, mammogram, PET, and nuclear medicine, searchable by modality and protocol.
Accelerate insights to real-world impact
Truveta helps organizations move faster across the product lifecycle: accelerating clinical trials, reducing post-market uncertainty and cost, optimizing launches, and understanding therapy adoption in real time.
With clinically rich, representative real-world data, teams can replace fragmented views with a single, living picture of how therapies perform, patients progress, and markets evolve.
AI training
Train and evaluate models with multimodal, longitudinal clinical data that reflects real patients, real care, and real-world complexity
Clinical trials
Improve study feasibility, identify eligible patients, and optimize trial design to reduce development risk and accelerate enrollment
Therapy adoption
Monitor treatment patterns, emerging trends, and unmet need to inform portfolio strategy, competitive positioning, and commercial planning
Safety
Detect safety signals earlier and evaluate long-term outcomes with longitudinal patient data to support regulatory commitments and lifecycle management
Outcomes research
Generate robust real-world evidence to demonstrate clinical and economic value for regulators, payers, providers, and healthcare decision-makers